You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/7484
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCarmo, Arturene M. L.-
dc.contributor.authorSilva, Flavia M. C.-
dc.contributor.authorMachado, Patricia A.-
dc.contributor.authorFontes, Ana P. S.-
dc.contributor.authorPavan, Fernando Rogério-
dc.contributor.authorLeite, Clarice Queico Fujimura-
dc.contributor.authorLeite, Sergio R. de A.-
dc.contributor.authorCoimbra, Elaine S.-
dc.contributor.authorDa Silva, Adilson D.-
dc.date.accessioned2014-05-20T13:24:16Z-
dc.date.accessioned2016-10-25T16:45:00Z-
dc.date.available2014-05-20T13:24:16Z-
dc.date.available2016-10-25T16:45:00Z-
dc.date.issued2011-06-01-
dc.identifierhttp://dx.doi.org/10.1016/j.biopha.2011.01.003-
dc.identifier.citationBiomedicine & Pharmacotherapy. Paris: Elsevier France-editions Scientifiques Medicales Elsevier, v. 65, n. 3, p. 204-209, 2011.-
dc.identifier.issn0753-3322-
dc.identifier.urihttp://hdl.handle.net/11449/7484-
dc.identifier.urihttp://acervodigital.unesp.br/handle/11449/7484-
dc.description.abstractA series of 4-amino-7-chloroquinoline derivatives were synthesized by the reaction of 4,7-dichloroquinoline with the corresponding diamine and then with propargyl bromide. In addition, platinum(II) complexes were obtained by reacting some of the organic derivatives with K(2)PtCl(4). Several of the synthesized compounds displayed antituberculosis activities. Compound 3 was 47.5 times more active than amphotericin B against Leishmania chagasi (IC(50) = 0.04 mu g/mL). Compounds 5, 6, 7, 9, 10, 11 and 13 presented promising results against Mycobacterium tuberculosis, with MIC values ranging from 12.5 to 15.6 mu g/mL, comparable to the "first and second line'' drugs used to treat tuberculosis. (C) 2011 Elsevier Masson SAS. All rights reserved.en
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)-
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)-
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)-
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)-
dc.description.sponsorshipBIC/UFJF-
dc.format.extent204-209-
dc.language.isoeng-
dc.publisherElsevier France-editions Scientifiques Medicales Elsevier-
dc.sourceWeb of Science-
dc.subject4-aminoquinoline analoguesen
dc.subjectPlatinum(II) complexesen
dc.subjectAntileishmanialen
dc.subjectAntitubercularen
dc.subjectLeishmaniaen
dc.subjectMycobacterium tuberculosisen
dc.titleSynthesis of 4-aminoquinoline analogues and their platinum(II) complexes as new antileishmanial and antitubercular agentsen
dc.typeoutro-
dc.contributor.institutionUniversidade Federal de Juiz de Fora (UFJF)-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.description.affiliationUniv Fed Juiz Fora, Dept Quim, ICE, BR-36036900 Juiz de Fora, MG, Brazil-
dc.description.affiliationUniv Fed Juiz Fora, Dept Parasitol Microbiol & Imunol, ICB, BR-36036900 Juiz de Fora, MG, Brazil-
dc.description.affiliationUniv Estadual Paulista, Fac Ciencias Farmaceut, BR-14801902 Araraquara, SP, Brazil-
dc.description.affiliationUniv Estadual Paulista, Inst Quim, BR-14801902 Araraquara, SP, Brazil-
dc.description.affiliationUnespUniv Estadual Paulista, Fac Ciencias Farmaceut, BR-14801902 Araraquara, SP, Brazil-
dc.description.affiliationUnespUniv Estadual Paulista, Inst Quim, BR-14801902 Araraquara, SP, Brazil-
dc.description.sponsorshipIdFAPESP: 08/10390-2-
dc.description.sponsorshipIdFAPESP: 09/06499-1-
dc.identifier.doi10.1016/j.biopha.2011.01.003-
dc.identifier.wosWOS:000296960200011-
dc.rights.accessRightsAcesso restrito-
dc.relation.ispartofBiomedicine & Pharmacotherapy-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.